CD274 and Kaposi's sarcoma: Indeed, KS tumors strongly express the T cell inhibitory molecules PD1 and PDL1 [24] and several promising results have recently emerged from pilot reports testing immune checkpoint inhibitors (ipilimumab and/or nivolumab), mainly in HIV-associated Kaposi Sarcoma (NCT02408861) [25,26,27].